Paper32754591
Tranilast Directly Targets NLRP3 to Protect Melanocytes From Keratinocyte-Derived IL-1β Under Oxidative Stress.
Zhuang T and 10 others. Front Cell Dev Biol, 2020. Cited by 32 papers, by iCite.
Cite this record
ConductScience Library. Tranilast Directly Targets NLRP3 to Protect Melanocytes From Keratinocyte-Derived IL-1β Under Oxidative Stress. Papers, record 32754591. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32754591
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Tranilast Directly Targets NLRP3 to Protect Melanocytes From Keratinocyte-Derived IL-1β Under Oxidative Stress.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19449448 | Physiological factors that regulate skin pigmentation. | Biofactors | 2009 | https://conductscience.org/library/papers/19449448 | PubMed |
| 2 | 28410442 | Development of an Acrylate Derivative Targeting the NLRP3 Inflammasome for the Treatment of Inflammatory Bowel Disease. | J Med Chem | 2017 | https://conductscience.org/library/papers/28410442 | PubMed |
| 3 | 23254930 | NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. | Nature | 2013 | https://conductscience.org/library/papers/23254930 | PubMed |
| 4 | 27686391 | Keratinocyte-Derived Chemokines Orchestrate T-Cell Positioning in the Epidermis during Vitiligo and May Serve as Biomarkers of Disease. | J Invest Dermatol | 2017 | https://conductscience.org/library/papers/27686391 | PubMed |
| 5 | 21978301 | HSP70i is a critical component of the immune response leading to vitiligo. | Pigment Cell Melanoma Res | 2012 | https://conductscience.org/library/papers/21978301 | PubMed |
| 6 | 26549800 | Molecular mechanisms regulating NLRP3 inflammasome activation. | Cell Mol Immunol | 2016 | https://conductscience.org/library/papers/26549800 | PubMed |
| 7 | 30998983 | Oxidative Stress-Induced HMGB1 Release from Melanocytes: A Paracrine Mechanism Underlying the Cutaneous Inflammation in Vitiligo. | J Invest Dermatol | 2019 | https://conductscience.org/library/papers/30998983 | PubMed |
| 8 | 24523323 | CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo. | Sci Transl Med | 2014 | https://conductscience.org/library/papers/24523323 | PubMed |
| 9 | 24662764 | Impaired activation of the Nrf2-ARE signaling pathway undermines H2O2-induced oxidative stress response: a possible mechanism for melanocyte degeneration in vitiligo. | J Invest Dermatol | 2014 | https://conductscience.org/library/papers/24662764 | PubMed |
| 10 | 25447595 | Tranilast: a review of its therapeutic applications. | Pharmacol Res | 2015 | https://conductscience.org/library/papers/25447595 | PubMed |
| 11 | 10537016 | In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. | J Investig Dermatol Symp Proc | 1999 | https://conductscience.org/library/papers/10537016 | PubMed |
| 12 | 21782231 | MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. | Cell | 2011 | https://conductscience.org/library/papers/21782231 | PubMed |
| 13 | 28003153 | Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice. | Brain Behav Immun | 2017 | https://conductscience.org/library/papers/28003153 | PubMed |
| 14 | 20835230 | Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. | Nat Immunol | 2010 | https://conductscience.org/library/papers/20835230 | PubMed |
| 15 | 26315342 | Oxidative stress-induced overexpression of miR-25: the mechanism underlying the degeneration of melanocytes in vitiligo. | Cell Death Differ | 2016 | https://conductscience.org/library/papers/26315342 | PubMed |
| 16 | 28778794 | Vitiligo: Mechanistic insights lead to novel treatments. | J Allergy Clin Immunol | 2017 | https://conductscience.org/library/papers/28778794 | PubMed |
| 17 | 16965270 | Rab7 and Rab27a control two motor protein activities involved in melanosomal transport. | Pigment Cell Res | 2006 | https://conductscience.org/library/papers/16965270 | PubMed |
| 18 | 25896941 | miR-196a-2 rs11614913 polymorphism is associated with vitiligo by affecting heterodimeric molecular complexes of Tyr and Tyrp1. | Arch Dermatol Res | 2015 | https://conductscience.org/library/papers/25896941 | PubMed |
| 19 | 29312598 | Interleukin-22 participates in the inflammatory process of vitiligo. | Oncotarget | 2017 | https://conductscience.org/library/papers/29312598 | PubMed |
| 20 | 23382179 | NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1β processing via the NLRP1 inflammasome. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/23382179 | PubMed |
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42518751 | Neuroinflammation in Alzheimer's disease-associated sensory dysfunction: mechanistic links, actionable targets and therapeutic strategies. | Front Aging Neurosci | 2026 | https://conductscience.org/library/papers/42518751 | PubMed |
| 42271078 | The challenge of cell death switching in inflammasome-targeted therapies for bacterial and viral infections. | Commun Biol | 2026 | https://conductscience.org/library/papers/42271078 | PubMed |
| 42105025 | Vitiligo as a Failure of Immune Resolution and Tissue Regeneration: From Stress Signals to Targeted Immune Modulation. | Clin Rev Allergy Immunol | 2026 | https://conductscience.org/library/papers/42105025 | PubMed |
| 41960577 | Tranilast ameliorates experimental abdominal aortic aneurysm by inhibiting the NLRP3 inflammasome pathway. | J Pharm Anal | 2026 | https://conductscience.org/library/papers/41960577 | PubMed |
| 41514124 | TKI-mediated inhibition of NLRP1 inflammasome restores erythropoiesis in DBA syndrome. | EMBO Mol Med | 2026 | https://conductscience.org/library/papers/41514124 | PubMed |
| 41454181 | Neuroimmune Dysregulation and AI-Driven Therapeutic Strategies in Alzheimer's Disease. | Cell Mol Neurobiol | 2025 | https://conductscience.org/library/papers/41454181 | PubMed |
| 41081382 | A Scoping Review of Pathogenesis, Current Treatments, and Novel Approaches for Vitiligo. | J Cosmet Dermatol | 2025 | https://conductscience.org/library/papers/41081382 | PubMed |
| 40001572 | Mechanisms of Resistance to Anti-PD-1 Immunotherapy in Melanoma and Strategies to Overcome It. | Biomolecules | 2025 | https://conductscience.org/library/papers/40001572 | PubMed |
| 39604503 | The role of NLRP3 and NLRP12 inflammasomes in glioblastoma. | Genes Immun | 2024 | https://conductscience.org/library/papers/39604503 | PubMed |
| 39272986 | Anti-Inflammatory Role of the Klotho Protein and Relevance to Aging. | Cells | 2024 | https://conductscience.org/library/papers/39272986 | PubMed |
| 38402320 | Novel antimicrobial peptides against Cutibacterium acnes designed by deep learning. | Sci Rep | 2024 | https://conductscience.org/library/papers/38402320 | PubMed |
| 38310392 | Targeting NLRP3 Inflammasome: Structure, Function, and Inhibitors. | Curr Med Chem | 2024 | https://conductscience.org/library/papers/38310392 | PubMed |
| 38177104 | The role of inflammasomes in human diseases and their potential as therapeutic targets. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/38177104 | PubMed |
| 37781032 | Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress. | Int J Biol Sci | 2023 | https://conductscience.org/library/papers/37781032 | PubMed |
| 37250107 | Insights into the Role of Inflammation in the Management of Atherosclerosis. | J Inflamm Res | 2023 | https://conductscience.org/library/papers/37250107 | PubMed |
| 36911371 | Tranilast reduces cardiomyocyte injury induced by ischemia‑reperfusion via Nrf2/HO‑1/NF‑κB signaling. | Exp Ther Med | 2023 | https://conductscience.org/library/papers/36911371 | PubMed |
| 35754962 | The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases. | Front Aging Neurosci | 2022 | https://conductscience.org/library/papers/35754962 | PubMed |
| 35515106 | Mechanisms of Immunotherapy Resistance in Cutaneous Melanoma: Recognizing a Shapeshifter. | Front Oncol | 2022 | https://conductscience.org/library/papers/35515106 | PubMed |
| 35251468 | The Current Status of Antioxidants in the Treatment of Vitiligo in China. | Oxid Med Cell Longev | 2022 | https://conductscience.org/library/papers/35251468 | PubMed |
| 35096274 | The Promising Role of Chemokines in Vitiligo: From Oxidative Stress to the Autoimmune Response. | Oxid Med Cell Longev | 2022 | https://conductscience.org/library/papers/35096274 | PubMed |
Genes33
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32754591
GET https://conductscience.org/api/papers/v1/32754591/references?page=2